Parkinson’s disease is a long-term condition that affects the brain and nervous system, disrupting everyday activities for millions worldwide. Its symptoms, including tremors, stiff muscles, and difficulty with balance and coordination, tend to worsen over time.
The exact cause of Parkinson’s remains unclear, but scientists are investigating factors that might increase the risk, including the potential role of antiepileptic drugs.
Antiepileptic drugs are widely used to control seizures in people with epilepsy and other seizure-related conditions. While these medications are crucial for managing such disorders, researchers have begun to explore whether they could also increase the risk of developing Parkinson’s disease.
A recent study led by scientists at Queen Mary University of London, published in JAMA Neurology, looked into this possible connection.
The study analyzed medical data from a large group of people in the UK. Researchers compared 1,433 people with Parkinson’s disease to 8,598 individuals without the disease (the control group).
By reviewing prescription records, they investigated whether participants had taken specific antiepileptic drugs, such as carbamazepine, lamotrigine, levetiracetam, and sodium valproate.
The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk appeared to be higher among individuals who had taken larger doses or multiple types of antiepileptic drugs.
This trend, known as a dose-response relationship, suggests that the more these medications are used, the greater the likelihood of developing Parkinson’s.
This research is notable because it is the first to examine a wide range of antiepileptic drugs in relation to Parkinson’s disease. Although the study provides valuable insights, it also raises many questions.
The reasons behind this link are still unclear, and more research is needed to understand the biological mechanisms that might connect antiepileptic drugs to Parkinson’s.
Despite these findings, it’s essential to emphasize that antiepileptic drugs are life-saving for many people. They help control seizures, prevent complications, and improve quality of life.
For those with epilepsy or other seizure disorders, the benefits of these medications often outweigh the potential risks. Any concerns about these drugs should be discussed with a healthcare provider before making changes to treatment.
This study highlights the importance of balancing the benefits and risks of medications, especially those used long-term. Doctors and patients should work together to make informed decisions, considering all available evidence and individual circumstances.
While this research provides important clues about Parkinson’s disease, it is just the beginning. Future studies will aim to confirm these results and dig deeper into why antiepileptic drugs might increase the risk.
Understanding these connections could shed light on how Parkinson’s develops and, in the long term, help identify strategies to lower the risk.
For now, people taking antiepileptic drugs should not be alarmed but should stay informed as research continues. This study serves as a reminder of how important it is to monitor medications and their effects over time, ensuring the best outcomes for both treatment and long-term health.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2025 Knowridge Science Report. All rights reserved.
